3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors
US5698584A · kind A · utility
43Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1996 |
| Grant date | Dec 16, 1997 |
| Priority date | — |
| Expiry date | Oct 25, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/117
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.